Feds seize $3 million from Wheat, Hi Tech

By Hank Schultz contact

- Last updated on GMT

Feds seize $3 million from Wheat, Hi Tech
The federal government has seized more than $3 million from Hi Tech Pharmaceuticals CEO Jared Wheat as part of its money laundering and mail fraud case against the executive and the dietary supplement company he controls.

The action, filed on Monday in the Northern District court in Georgia, seeks authorization to keep $1.8 million taken from one account and $1.2 million seized from another. The funds are “traceable to one or more unlawful activities​ and thus subject to seizure, according to the order.  The seizure order relates these illegal activities to profits from the sale of products alleged to contain illegal anabolic steroids, and the money laundering has to do with moving these alleged ill-gotten gains back and forth between the accounts.

The initial indictment, which was also filed in Northern District of Georgia, alleges that Wheat and his company drew up fraudulent ‘certificates of free sale’ for products that made it appear as if they had been issued by the Food and Drug Administration.  FDA will upon request supply these certificates, which are occasionally requested by importers in other countries who are buying US products, that according to the indictment indicate that, “The food product is marketed in the United States and eligible for export if certain statutory provisions are met.  ​According to the indictment, Wheat and Schopp (who was identified as Hi Tech’s manager of manufacturing operations) supplied to customers “misleading documents and representations regarding the regulatory compliance of HI-TECH and its products, including false, fraudulent, and misleading FDA Certificates of Free Sale, GMP certificates, and GMP audit reports.

Sale of steroids

Wheat is also alleged to have sold products containing anabolic steroids masquerading as supplements by calling these substances ‘pro-hormones.’  According to the indictment, the products, “In fact contained Schedule III Controlled anabolic steroids not properly declared as ingredients on the products' respective labeling.

The products cited in the initial indictment are:

  • Superdrol, which is alleged to contain contained androstanedione, 4-androstenediol and/or 5-androstenediol, and boldione;
  • Equibohn, which allegedly contains 4-androstenediol and/or 5-androstenediol;
  • 1-AD, which allegedly contains boldione, androstanedione, 4-androstenediol and/or 5-androstenediol;
  • 1-Testosterone, said to contain boldione and androstanedione
  • Androdiol, alleged to contained 4-androstenediol and/ or 5-androstenediol.

Related products

show more

Setting Specifications – Don’t Forget To Do This!

Setting Specifications – Don’t Forget To Do This!

Gemini Pharmaceuticals | 12-Feb-2018 | Technical / White Paper

While the regulations require Brand Owners to establish specifications for all raw materials and for the finished product, based on the number of FDA Warning...

Feeling low T-levels?

Feeling low T-levels?

Chemical Resources (CHERESO) | 12-Feb-2018 | Application Note

Healthy testosterone levels influence a broad range of men’s health goals, from maintaining healthy sexual function to supporting optimal athletic performance.

Today’s Weight Management Consumer

Today’s Weight Management Consumer

Kemin Human Nutrition & Health | 18-Jan-2018 | Infographic

The weight management market has an estimated value of $34 billion. As the percentage of overweight and obese consumers continues to rise globally, there...

Putting Weight into Weight Loss Claims

Putting Weight into Weight Loss Claims

KGK Science, Inc. | 18-Jan-2018 | Technical / White Paper

With a growing number of people who are busier, turning to fast food & leading more sedentary lifestyles, quick fixes to shed excess pounds and get...

Related suppliers

Follow us

Products

View more

Webinars